According to GuruFocus Insider Data, the largest insider sells during the past week were: Facebook Inc. (FB, Financial), Aetna Inc. (AET, Financial), Regeneron Pharmaceuticals Inc. (REGN, Financial) and Tyco International PLC (TYC, Financial).
The overall trend of insiders is illustrated in the chart below:
Facebook Inc.: Director Peter Thiel sold 1,072,033 shares
Director Peter Thiel sold 1,072,033 shares of Facebook stock on 08/11/2015 at the average price of $93.66. Peter Thiel owns at least 1,072,033 shares after this. The price of the stock has increased by 0.29% since.
Facebook Inc. has a market cap of $264.65 billion; its shares were traded at around $93.93 with a P/E ratio of 96.00 and P/S ratio of 17.86.
Facebook has released its second quarter 2015 results ended June 30, 2015. Revenue in this quarter was $4.04 billion, up 39% over revenue of $2.91 billion in the second quarter of 2014. Net income decreased 9% to $719 million, and diluted EPS was down 17% to $0.25. On a non-GAAP basis, diluted EPS was $0.50 compared to $0.43 in the prior year quarter.
VP, Gen. Counsel & Secretary Colin Stretch sold 1,000 shares of FB stock on 08/11/2015 at the average price of $93.75.
Aetna Inc.: Senior EVP Joseph M Zubretsky sold 179,087 shares
Senior EVP of Aetna Inc. Joseph M Zubretsky sold 179,087 shares on 08/14/2015 at an average price of $123.04.
Aetna offers traditional, voluntary and consumer-directed health insurance products. The company has a market cap of $42.89 billion; its shares were traded at around $123.04 with a P/E ratio of 18.66 and P/S ratio of 0.72. Its dividend yield is 0.79%, and the company had an annual average earnings growth of 12.30% over the past 10 years. GuruFocus rated Aetna Inc the business predictability rank of 5-star.
For its second quarter of 2015, Aetna reported net income up 33% to $731.8 million, with operating earnings per share up 21% at $2.05.
Director Franklin Barbara Hackman sold 2,064 shares of AET stock on 08/13/2015 at the average price of $118.47.
Regeneron Pharmaceuticals Inc.: SVP Clinical Development and Reg Peter Powchik sold 23,485 Shares
SVP Peter Powchik sold 23,485 shares of Regeneron stock on 08/14/2015 at the average price of $573.38. Peter Powchik owns at least 30,363 shares after this. The price of the stock has increased by 0.59% since.
Regeneron Pharmaceuticals Inc has a market cap of $59.8 billion; its shares were traded at around $576.76 with a P/E ratio of 143.62 and P/S ratio of 19.58.
Second-quarter revenues were $999 million for Regeneron Pharmaceuticals, which was up 50% over the $666 million reported in the year-ago period. GAAP net income was up 103% to $195 million. Non-GAAP net income was up 17% at $338 million, or $2.89 per share. The company recently announced FDA approval of Praluent for hypercholesterolemia.
SVP Finance & CFO Robert E Landry sold 4,000 shares of REGN stock on 08/05/2015 at the average price of $592.84.
Tyco International PLC: Director Edward D. Breen sold 320,965 shares
Director of Tyco International PLC Edward D. Breen sold 320,965 shares on 08/12/2015 at an average price of $37.97.
Tyco International PLC was organized under the laws of Switzerland. The company has a market cap of $16 billion; its shares were traded at around $37.97 with a P/E ratio of 40.58 and P/S ratio of 1.62. The dividend yield of Tyco International PLC stocks is 2.03%.
Tyco International PLC has reported its third quarter 2015 results. Organic revenue decreased 1% over the prior year quarter, while income from continuing operations went down 57% to $188 million. Income from continuing operations before special items was down 1% at $251 million.
CEO George Oliver sold 22,591 shares of TYC stock on 08/04/2015 at the average price of $38.43.
For the complete list of stocks that bought/sold by their company executives, go to: Insider Buys.